ImmuPharma Plc

(LSE) IMM

Current Price£0.05

Market Cap£28.70M

Since IPO (2006)-91%

5 Year-46%

1 Year+88%

1 Month+5%

ImmuPharma Plc Financials at a Glance

Market Cap

£28.70M

Revenue (TTM)

£0.00

Net Income (TTM)

-£2.86M

EPS (TTM)

-£0.00

P/E Ratio

-12.11

Dividend

£0.00

Beta (Volatility)

0.31 (Low)

Dividend

£0.00

Beta (Volatility)

0.31 (Low)

Price

£0.05

Volume

2,070,772

Open

£0.05

Price

£0.05

Volume

2,070,772

Open

£0.05

Previous Close

£0.05

Daily Range

£0.05 - £0.05

52-Week Range

£0.01 - £0.19

Estimated Earnings Date

Sep 24, 2026

Dividend

£0.00

Beta (Volatility)

0.31 (Low)

Price

£0.05

Volume

2,070,772

Open

£0.05

Previous Close

£0.05

Daily Range

£0.05 - £0.05

52-Week Range

£0.01 - £0.19

Estimated Earnings Date

Sep 24, 2026

IMM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImmuPharma Plc

Industry

Pharmaceuticals

Sector

Health Care

CEO

Tim McCarthy McCarthy, MBA

Website

www.immupharma.com

Headquarters

London, EC1A 7BL, GB

IMM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-2511%

Return on Capital

-7%

Return on Assets

-2%

Earnings Yield

-8.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£28.70M

Shares Outstanding

623.91M

Volume

2.07M

Avg. Volume

2.51M

Financials (TTM)

Gross Profit

-£35.30K

Operating Income

-£2.54M

EBITDA

-£2.51M

Operating Cash Flow

-£2.37M

Capital Expenditure

-£1.66K

Free Cash Flow

-£2.37M

Cash & ST Invst.

£1.35M

Total Debt

£0.00

ImmuPharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

£0.00

N/A

Gross Profit

-£6.77K

N/A

Gross Margin

0.00%

N/A

Market Cap

£28.70M

N/A

Market Cap/Employee

£5.74M

N/A

Employees

N/A

Net Income

£31.21K

+103.0%

EBITDA

-£1.30M

-39.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

£1.35M

+470.8%

Total Debt

£0.00

N/A

Accounts Receivable

£462.24K

N/A

Inventory

£0.00

N/A

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

-1.52%

N/A

Return on Invested Capital

-6.80%

N/A

Free Cash Flow

-£1.37M

-205.4%

Operating Cash Flow

-£1.36M

-205.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SPEC.LINSPECS Group plc

SPEC.LINSPECS Group plc£0.97+14.20%

EAH.LECO Animal Health Group plc

EAH.LECO Animal Health Group plc£0.92-0.54%

CREO.LCreo Medical Limited

CREO.LCreo Medical Limited£0.14+0.00%

KOO.LKooth plc

KOO.LKooth plc£1.62-0.62%

HVO.LhVIVO plc

HVO.LhVIVO plc£0.08+0.00%

POLB.LPoolbeg Pharma PLC

POLB.LPoolbeg Pharma PLC£0.08-2.92%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc£7.78+4.36%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.42-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$17.42-0.02%

NOKNokia

NOKNokia$13.83-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

HOODRobinhood Markets

HOODRobinhood Markets$105.20+0.09%

Questions About IMM

What is the current price of ImmuPharma Plc?

ImmuPharma Plc is trading at £0.05 per share.

What is the 52-week range for ImmuPharma Plc?

Over the past 52 weeks, ImmuPharma Plc has traded between £0.01 and £0.19.

How much debt does ImmuPharma Plc have?

As of the most recent reporting period, ImmuPharma Plc reported total debt of £0.00.

How much cash does ImmuPharma Plc have on hand?

ImmuPharma Plc reported £1.35M in cash and cash equivalents in its most recent financial results.

What is ImmuPharma Plc’s dividend yield?

ImmuPharma Plc does not currently have a dividend yield.

ImmuPharma Plc

ImmuPharma Plc Financials at a Glance

IMM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ImmuPharma Plc

IMM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ImmuPharma Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMM

What is the current price of ImmuPharma Plc?

What is the 52-week range for ImmuPharma Plc?

How much debt does ImmuPharma Plc have?

How much cash does ImmuPharma Plc have on hand?

What is ImmuPharma Plc’s dividend yield?

Premium Investing Services